Pete Gundermann
Analyst · C.L. King & Associates. Please proceed with your question
Thanks, Debbie; and good morning, everybody. And before we get going, I should assure you that I am in fact Pete, and my voice doesn't sound normal. I've been assured that whatever I have you can't catch over the phone. So, I apologize in advance. I may get hit with a cough attack here sometime over the course of the call and I'm -- got the mute button ready to go. I'm not afraid to use it. So if I go silent for a minute, that's what that's all about. But everything being equal on that, we'll talk about our fourth quarter results, which we feel pretty good about, and do a post-mortem on 2018, which we feel was a pretty strong year for the Company, and then we'll turn our attention to 2019. As usual, there are some issues to talk about there, primarily relating to the sale of the semi test business that we announced on the 13th of this month, and -- or didn't announce, but closed on the 13th of this month; and also some of the issues that are likely to affect our 2019 including primarily the three businesses that we've dedicated some space to over the last couple of calls, we'll continue to do that today. So with that as a backdrop, our fourth quarter ended up pretty strong; revenue of $203 million, was our consolidated, was our third highest ever after only the previous two quarters, the second and third quarter of 2018. Our fourth quarter results were up 18% over the comparator period of a year ago, that's about $32 million of growth. Acquisitions contributed $12 million of the $32 million of growth, and organic was the rest $20 million or about 12% organic growth year-over-year. Our Aerospace segment had a particularly strong quarter. We set another revenue record of $175 million in the fourth quarter. That's our fourth record quarter in a row, and up 25% over the comparator period at the end of 2017. Our Test business was relatively light, revenue of $27.7 million, that was pretty much what we expected, and predicted at the end of our last press release or last quarterly conference call. That result of 27.7 million was below both the comparator period of a year ago, and well below the second and third periods of last year. Second and third quarters of 2018 were relatively strong for our Test business. Net income in the quarter was strong at 12.5 million or 6.2% of sales. That's up dramatically from the comparator period, when we had a large impairment charge at our Armstrong business at the end of 2017 of 16.2 million, due in the year-over-year comparisons that colors the comparisons substantially got to keep that in mind as you look at the older numbers. Aerospace, again, was a solid contributor with operating margins of 12.7%. That's not where we wanted to be, but it's the highest we've had in quite a while and it shows signs of improvement. Our three struggling businesses that we've talked about, CCC, AeroSat, Armstrong, we've talked about them collectively as a group now for about nine months, and they turned in a combined operating loss in the fourth quarter of 6.4 million. We're not particularly happy with that. That's below where we thought we would be, but it is down substantially from the third quarter when the three turned in an operating loss of 11.2 million. So, 11.2 million to 6.4 million, we think is pretty good improvement. We expect continued improvement from here, we'll talk about that more specifically at the end of the call. Diluted earnings per share in the fourth quarter were $0.37 versus a loss of $0.18 in the comparator period a year ago; again, because of that impairment charge at Armstrong. Not only good shipments and margins but bookings were pretty strong. We ended up with bookings in the fourth quarter of 220 million consolidated, that's a book-to-bill of 1.09. Aerospace bookings were right there with shipments, even on an all-time record shipping quarter book-to-bill of 1. Test had a pretty strong booking quarter of 45 million, a book-to-bill of 1.62. The star in that arsenal has to do with a number of things, but some progress we made with the New York City program for $30 million is achieved part of that. Backlog at the end of the year was 415 million, a record high, included in that total is 12 million of backlog that was essentially sold with the semi test business in February to our friends at Advantest. Year-to-date -- year-to-conclude, I guess, at the end of 2018, we ended up with revenues of 803 million, that was up pretty substantially 28% from 624 million in 2017. That's total growth of $179 million, and roughly split equally between acquisitions and organic growth. Acquisitions contributed $85 million of the $179 million of growth. Organically, we generated $94 million of growth. Net income for the year ended up at $46.9 million or 5.8% of sales, up 138% from $19.7 million in 2017 or $1.41 per diluted share versus $0.58 per diluted share in 2017. Net income for the year was positively impacted by the lower federal tax rate and a change in our state tax position that we talked about on the last call, and negatively affected again by the combined operating losses of $34.7 million of the struggling three businesses. Again, we're not happy with $34.7 million. It compares about the same as 2017 when those three businesses combined for $47.1 million, inclusive of the impairment charge at Armstrong. So, $47.1 million in 2017 and $34.7 million in 2018, we're looking for substantial improvement in 2019 as -- and we'll get to that in a minute. Total bookings for 2018 came in at $837 million, that's vesting shipments by about 4%, Aerospace bookings were up about 5%, Test bookings were down about 2%. Looking more specifically at our segments. Our Aerospace quarter as I said, was a really strong quarter, record revenues of $175.2 million, up 25%, 26% compared to $140 million in the comparator period. That's our fourth new record in a row for our Aerospace segment. Operating profit came in at $22.2 million or 12.7% of sales, not exactly where we are striving to be, but it is the highest we've achieved in three years. If one were inclined to run the exercise and back out the losses from three stragglers of $6.4 million or assume that we could get those businesses to break even, operating profit in the quarter would have been 16.4%. So, we continue to believe that our best margin improvement opportunities to continue to focus on reducing the operating losses of those three businesses, and we think we're making progress. Bookings, as I mentioned moments ago, for the Aerospace segment in the fourth quarter were $175.5 million, slightly ahead of shipments book-to-bill of 1 and our Aerospace ending backlog of $326 million is our highest ever and sets us up well for entry into 2019. Looking back at the whole year for our Aerospace segment, revenues of $676 million were up 26% from 2017. They made up 84% of our consolidated total with the sale of our semi test business, that 84% in the future will increase, it will increase over 90% of our total. Operating profit for the year was $70 million or 10.3% of sales compared with $39 million in 2017. Again, for the year, the three troubled businesses that we're working with had an operating loss of $34.7 million. If you were to do the exercise to assume they were a breakeven, our Aerospace segment operating profit would have come in at about 15.4%. Looking the year-to-date were $712 million, so even with the record shipments, bookings of seated shipments by 5% over the course of the year. Looking at some of the tables that we put in our press release and specifically at the sales by product line table on the bottom of Page 10 of our press release, our Aerospace business these days continues to be well balanced in my opinion, our Electrical Power & Motion product line makes up about 38% of our consolidated sales. Our Lighting & Safety product line makes up about 22% and Avionics adds in about 16%, and they're all doing pretty well. Electrical Power & Motion was up almost 15% for the year and 29% for the quarter, that's a combination of a couple of things, primarily in that grouping is our in-seat power product, which continues to do very well, but the other big contributor there, increasingly is a seat motion capability that we have, where we have picked up quite a bit of market share over the last year-and-a-half and it's becoming a pretty good contributor to our overall consolidated result certainly helping to explain that growth. Our Avionics product line, chart shows up 144% for the year, that is largely because that's where the revenues that come from our Telefonix acquisition of December of 2017 ends up being categorized, mostly in our Avionics product line. And Lighting & Safety is up 10% of the year. So, obviously a good indicator when your three biggest product groupings are up strongly. That's nice to be able to report that at the end of the year. Switching over to our Test business. In the quarter, revenues, as I mentioned, were light as expected; came in at $27.7 million, that's down about 13% from last year and well after the pace from the second quarter and third quarter, the volume was pretty much dictated by schedules, which are dictated by customers. So, we knew it was coming, we were not surprised. Our operating profit for the segment in the fourth quarter on that lower volume was pretty meager $600,000, 2% of sales. However, Test had a pretty strong 2018. Revenue for the year was $127.7 million, that's up 42% from $90 million in 2017. Operating profit on that volume was 10.7 million, 8.4% of sales. If you look at the charts again on Page 10 of our press release, you can see pretty easily that the year was driven by relatively strong semiconductor demand. Semiconductor demand more than doubled going from $32 million in revenues in 2017 up to $84 million in 2018. We'll come back to semiconductor in just a minute. Bookings for the quarter were 45 million, that's a book-to-bill of 1.62; as I mentioned, very strong. And year-to-date bookings were 125 million versus shipments that are 127 million, that's a book-to-bill of 0.98. It ends our quarter with a Test backlog of $90 million. So a few words on the sale of the semiconductor product line. No doubt, people remember that in December, we announced a plan to transaction to sell the business, the product line to a company called Advantest for 185 million in cash at closing, an earn-out opportunity of 30 million and a contract manufacturing arrangement, which was to last for approximately four years. Last week, on February 14th, I guess, we issued a press release saying we had closed, but under substantially different terms. It was 100 million cash at closing with an earn-out opportunity of 35 million and no contract manufacturing arrangement. And the simple explanation for what happened there is, we, at the end of the year, were badly surprised by some changes in expectations on the part of some programs that we had been working toward and they had a material change on the value of the business. Excuse me, I'm happy to get this far through the script actually. And the change in forecast was substantial enough to cause the change in the valuation of the business. If I bring you back to Page 10, again, those product line charts or tables that we put in the press release, again, you can see in 2017 we had semiconductor semiconductor revenue of about 32 million; in 2018, it was 84 million. We had been expecting at 2019 that was roughly at that same elevated level and we expected, based on visibility, that 2020 would be a step change above that, and instead learned in late-December that, for us, if the business stayed in our hands, 2019 was likely to revert back to 2017 more than anything else. So that was disappointing for us, and it was a surprise to us also, but it was also when you look at it in context of what's going on in the world with trade tensions and semiconductor industry trends in general and consumer electronics trends in general, in retrospect, maybe not such a surprise. So we weren't happy going down from 185 million cash at closing to 100 million, but at the end of the day, we decided that was a better thing to do, first of all the business we think is frankly better off with Advantest than us. They have a global reach, they're not a US company which has some benefit in today's world and they have a much more comprehensive product line which -- and presence in a wider array of customers around the world. What it allows for us to do is to focus more specifically on our primary Aerospace business, that's focusing both in our internal operations and also in our external communications and dealing with the investor community in general, and the contract manufacturing thing means that we will have a little bit more of an abrupt change, but we believe that we are ready for that and we think we can make it work and we think that when we get to the forecast section and you look at the backlog that we have in place for Aerospace and Defense Test business that we're in pretty good shape to have this event happen today. I think I'm going to go on mute for a second, Dave, and let you talk about balance sheet, because we've generated some cash not only with the sell, both our results in the fourth quarter.